In stark contrast, levofloxacin resistance showed a remarkable and sustained decrease from about 65% in 2022 to < 5% in 2023 and 2024, highlighting a rare and highly significant positive development.
← all excerpts
Antimicrobial resistance trends of ESKAPEE pathogens isolated from intensive care unit patients at a tertiary care hospital in Mogadishu, Somalia: a retrospective study (2020-2024).
1
—
—